We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Yale University Purchases Sequenom MassARRAY Platform
News

Yale University Purchases Sequenom MassARRAY Platform

Yale University Purchases Sequenom MassARRAY Platform
News

Yale University Purchases Sequenom MassARRAY Platform

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Yale University Purchases Sequenom MassARRAY Platform"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Sequenom, Inc.  has announced the purchase by the W.M. Keck Foundation Biotechnology Resource Laboratory at Yale University of Sequenom's MassARRAY® system.

Yale plans to use the system as a platform for genotyping, copy number variation (CNV), methylation and quantitative gene expression (QGE) applications.

"The W.M. Keck Foundation Biotechnology Resource Laboratory is a highly respected institution, making this a particularly important placement," said Mike Monko, SEQUENOM'S Senior Vice President, Sales and Marketing.

"The MassARRAY system's ability to provide multiple applications for genetic research on a single platform has promoted the placement of our platform into almost all major university core laboratories."

Shrikant M. Mane, Ph.D., Director of Microarray Resources at the W.M. Keck Facility, stated, "Service requests from Yale researchers as well as other third-party organizations have significantly increased, prompting our purchasing decision. After conducting a thorough analysis of competing platforms in the gene- and whole-genome and fine-mapping and validation genetic analysis markets, we chose Sequenom's MassARRAY technology as the platform that best suits our numerous requirements."

Advertisement